Laser marking technology is “essential” to tracking reusable medical devices, engineers have developed a way to detect physiological signals coming from the skin, a robotic surgical developer raises £195m in funding, and a CE-marked app detects 95% of skin cancer.
Novo Nordisk is to launch a cut-price version of its insulin drug, a Slovakian biotech sees positive developments in its Alzheimer’s drug, the NHS looks at making statins available for pharmacists, and AZ’s cancer drug Imfinzi shows significant survival benefits.
The BMA warns a no-deal Brexit could worsen a winter healthcare crisis, NICE recommends a novel gene therapy for a rare inherited eye disorder, NHS nurses are to be given funding to help develop their careers, and NHS Digital pushes the pros of digital tools.
A review documents the rise of wearable medical devices, the Neurorehabilitation devices market is expected to expand with the prevalence of disorders, an accelerator backs two innovations with £150k, and the devices packaging industry is set to grow by $12.7 billion.
PM Boris Johnson orders action to crack down on measles, a leaked document forecasts no-deal Brexit shortages, both AbbVie and Celgene receive approval from the FDA, and experts in digital health warn that AI may not be able to keep up with ‘real-world’ medical use.
The average wait for GP appointments tips over the two-week mark for the first time, the UK government and DHSC is to invest £250 million in AI to deliver enhanced healthcare, and Ebola drugs show a ‘90% survival rate’ in a breakthrough trial.
‘Smart’ hearing aids can now stream music and monitor wearers’ health, massive growth is expected in the medical devices outsourcing market, an app helps detect acute kidney injury, and a report looks at how post-Brexit regulation could affect healthcare.
A Convergence Science Centre is launched to accelerate cancer treatments, Switzerland and Lichtenstein’s Director for International Trade says the UK offers unique opportunities for export and investment, and Pfizer confirms its generics merger with Mylan.
NICE is set to review how it develops guidance on drugs, apps are a crucial step on the road to greater efficiency in care, the UK government looks to boost AI in preventative healthcare, and an ‘essential’ nursing review is scrapped.